Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

MGI Pharma and Schein reach marketing agreement for INFeD

March 14, 1997

MP-52 enters clinic

March 14, 1997

Combination of immunosuppression and rhIL-3 for aplastic anemia

March 14, 1997

SKB discloses improved antihyperlipidemic agent

March 13, 1997

Advanced-generation matrix HRT patch launched in U.K.

March 12, 1997

Green Cross claims hypolipidemic agents

March 12, 1997

Recombinant human hemoglobin produced by transgenic tobacco

March 11, 1997

Millennium obesity gene patent application receives U.S. notice of allowance

March 10, 1997

Axcan signs distribution agreements for Protectaid

March 10, 1997

AY-4166: preclinical toxicity and pharmacokinetics studies

March 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...